Processes such as cellular proliferation, differentiation, growth and apoptosis are regulated in part by numerous extracellular factors including cytokines. These glycoproteins, which have an immunomodulatory role, are also mainly secreted by cells of the immune system. They perform their paracrine, juxtacrine, autocrine or endocrine actions by binding to specific cytokine receptors at the cell surface. A subset of cytokines triggers the JAK/STAT pathway to exert biological functions 1,2 (Figure 1). Their receptors are homodimers or hetero-dimers/trimers of transmembrane proteins that lack intracellular kinase activity. Instead, they rely on constitutive association with intracellular tyrosine kinases called Janus kinases (JAK) for the transduction of cytokine signalling.The Janus kinase family consists of four members: JAK1, JAK2, JAK3 and TYK2 that are ubiquitously expressed, except for JAK3 whose expression is restricted to cells of the haematopoietic lineage. JAKs, which are associated with the juxta-membrane domain of the receptor, become active when cytokine binds the receptor. Following this binding, the receptor undergoes intracellular conformational changes that result in its re-orientation or oligomerization. This initiates the signalling process by juxtaposing